The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Metabolic syndrome in liver transplant recipients: Prevalence, risk factors, and association with cardiovascular events
Open accessAbstract
Features of metabolic syndrome are not uncommon in patients after liver transplantation. To examine the prevalence and risk factors of posttransplantation metabolic syndrome (PTMS), the files of 252 transplant recipients (mean age, 54.5 ± 2.8 years, 57.9% male) were reviewed for pretransplant and posttransplant clinical and laboratory parameters (mean follow-up, 6.2 ± 4.4 years). Rates of obesity (body mass index >30 kg/m 2), hypertriglyceridemia (>150 mg/dL), high-density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women), hypertension, and diabetes were significantly higher after transplantation than before. Metabolic syndrome was diagnosed in 5.4% of patients before transplantation and 51.9% after. Besides significantly higher rates of the typical metabolic derangements (P < 0.0001), the patients with PTMS were older and heavier than those without PTMS, and they had a higher rate of pretransplant hepatitis C virus infection (P < 0.03) and more posttransplant major vascular and cardiac events (20 events in 15.2% of patients with PTMS versus 6 events in 4.9% of patients without PTMS; P < 0.007). There was no between-group difference in mortality or causes of death (mainly related to recurrent disease, graft failure, and sepsis). Significant independent predictors of PTMS on logistic regression analysis were age (odds ratio [OR] = 1.04), pretransplant nonalcoholic fatty liver disease (OR = 3.4), body mass index (OR = 1.13), diabetes (OR = 5.95), and triglycerides (OR = 1.01). The rate of metabolic syndrome in liver transplant recipients is more than twice that reported for the general population. PTMS is associated with cardiovascular morbidity but not mortality, and it may be predicted by pretransplantation conditions. Prospective studies are required to determine the significance and management of PTMS. Liver Transpl 17:15-22, 2011. © 2011 AASLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Malik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L’Italien, G. J., Pio, J. R., & Williams, G. R. (2004) · Circulation · doi:10.1161/01.cir.0000140677.20606.0e · Cited by 1,848
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Tsukamoto, K., Kimura, S., Moriya, K., & Koike, K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.056 · Cited by 763
Diagnosing Insulin Resistance in the General Population
McAuley, K. A., Williams, S. M., Mann, J. I., Walker, R. J., Lewis-Barned, N. J., Temple, L. A., & Duncan, A. W. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.460 · Cited by 752
Contos, M. J., Cales, W., Sterling, R. K., Luketic, V. A., Shiffman, M. L., Mills, S. A., Fisher, R. A., Ham, J., & Sanyal, A. J. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23011 · Cited by 400
Cardiovascular morbidity and mortality after orthotopic liver transplantation
Johnston, S. D., Morris, J. K., Cramb, R., Gunson, B. K., & Neuberger, J. (2002) · Transplantation · doi:10.1097/00007890-200203270-00012 · Cited by 322
Laryea, M., Watt, K. D., Molinari, M., Walsh, M. J., McAlister, V. C., Marotta, P. J., Nashan, B., & Peltekian, K. M. (2007) · Liver Transplantation · doi:10.1002/lt.21126 · Cited by 314
Weight gain and obesity after liver transplantation
Richards, J., Gunson, B., Johnson, J., & Neuberger, J. (2005) · Transplant International · doi:10.1111/j.1432-2277.2004.00067.x · Cited by 283
Analysis of causes of death in liver transplant recipients who survived more than 3 years
Pruthi, J., Medkiff, K. A., Esrason, K. T., Donovan, J. A., Yoshida, E. M., Erb, S. R., Steinbrecher, U. P., & Fong, T.-L. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.27084 · Cited by 280
LONG-TERM MEDICAL COMPLICATIONS IN PATIENTS SURVIVING ???5 YEARS AFTER LIVER TRANSPLANT
Sheiner, P. A., Magliocca, J. F., Bodian, C. A., Kim-Schluger, L., Altaca, G., Guarrera, J. V., Emre, S., Fishbein, T. M., Guy, S. R., Schwartz, M. E., et al. (2000) · Transplantation · doi:10.1097/00007890-200003150-00018 · Cited by 262
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease
Ong, J., Younossi, Z. M., Reddy, V., Price, L. L., Gramlich, T., Mayes, J., & Boparai, N. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.24644 · Cited by 258
Metabolic syndrome in liver transplantation: Relation to etiology and immunosuppression
Bianchi, G., Marchesini, G., Marzocchi, R., Pinna, A. D., & Zoli, M. (2008) · Liver Transplantation · doi:10.1002/lt.21588 · Cited by 257
EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE AFTER RENAL TRANSPLANTATION
Kasiske, B. L. (2001) · Transplantation · doi:10.1097/00007890-200109271-00003 · Cited by 237
Outcome After Liver Transplantation for NASH Cirrhosis
Malik, S. M., DeVera, M. E., Fontes, P., Shaikh, O., & Ahmad, J. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02590.x · Cited by 207
Canzanello, V. J., Schwartz, L., Taler, S. J., Textor, S. C., Wiesner, R. H., Porayko, M. K., & Krom, R. A. F. (1997) · Liver Transplantation and Surgery · doi:10.1002/lt.500030101 · Cited by 197
Stegall, M. D., Everson, G. T., Schröter, G., Bilir, B. M., Karrer, F. M., & Kam, I. (1995) · PubMed · Cited by 177
Hepatitis C-related cirrhosis: A predictor of diabetes after liver transplantation
Bigam, D. L., Pennington, J. J., Carpentier, A. C., Wanless, I. R., Hemming, A. W., Croxford, R., Greig, P. D., Lilly, L., Heathcote, J., Levy, G. A., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.8270 · Cited by 155
New onset diabetes mellitus after liver transplantation: The critical role of hepatitis C infection
Khalili, M., Lim, J., Bass, N. M., Ascher, N. L., Roberts, J. P., & Terrault, N. A. (2004) · Liver Transplantation · doi:10.1002/lt.20092 · Cited by 151
Hanouneh, I. A., Feldstein, A. E., McCullough, A. J., Miller, C. M., Aucejo, F., Yerian, L. M., López, R., & Zein, N. N. (2008) · Liver Transplantation · doi:10.1002/lt.21524 · Cited by 114
Is there disparity between risk and incidence of cardiovascular disease after liver transplant?
Neal, D. A. J., Tom, B. D. M., Luan, J., Wareham, N. J., Gimson, A. E., Delrivière, L., Byrne, C. D., & Alexander, G. (2004) · Transplantation · doi:10.1097/01.tp.0000100685.70064.90 · Cited by 105
The metabolic effects of cyclosporin and tacrolimus
Marchetti, P., & Navalesi, R. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343761 · Cited by 88
Prevention of Post-transplant Cardiovascular Disease – Report and Recommendations of an Ad Hoc Group
Bostom, A. G., Brown, R. S., Chavers, B. M., Coffman, T. M., Cosio, F. G., Culver, K. W., Curtis, J. J., Danovitch, G. M., Everson, G. T., First, M. R., et al. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20602.x · Cited by 77
Reducing the Risks of Cardiovascular Disease in Liver Allograft Recipients
Mells, G. F., & Neuberger, J. (2007) · Transplantation · doi:10.1097/01.tp.0000262706.28513.6a · Cited by 76
Saab, S., Shpaner, A., Zhao, Y., Brito, I., Durazo, F. A., Han, S. H. B., Farmer, D. G., Ghobrial, R. M., Yersiz, H., Goldstein, L. I., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01385.x · Cited by 58
Delgado‐Borrego, A., Liu, Y.-S., Jordan, S. H., Agrawal, S., Zhang, H., Christofi, M., Casson, D. R., Cosimi, A. B., & Chung, R. T. (2008) · Liver Transplantation · doi:10.1002/lt.21267 · Cited by 56
Cauble, M. S., Gilroy, R. K., Sorrell, M. F., et al. (2001) · Transplantation · doi:10.1097/00007890-200104150-00012 · Cited by 48
Post-liver transplant obesity and diabetes
Correia, I., Rego, L. O., & Lima, A. S. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000078994.96795.d8 · Cited by 34
(2008) · PubMed · Cited by 32
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Lucey, M. R., Terrault, N., Ojo, L., Hay, E. J., Neuberger, J., Blumberg, E., & Teperman, L. W. (2013) · Liver Transplantation · doi:10.1002/lt.23566 · Cited by 544
Charlton, M., Levitsky, J., Aqel, B., O'Grady, J., Hemibach, J., Rinella, M., Fung, J., Ghabril, M., Thomason, R., Burra, P., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002147 · Cited by 310
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Kang, S. H., Lee, H. W., Yoo, J.-J., Cho, Y., Kim, S. U., Lee, T. H., Jang, B. K., Kim, S. G., Ahn, S. B., Kim, H., et al. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0178 · Cited by 267
Tsamalaidze, L., Stauffer, J. A., Arasi, L. C., Villacreses, D. E., Franco, J. S. S., Bowers, S., & Elli, E. F. (2018) · Obesity Surgery · doi:10.1007/s11695-017-2847-7 · Cited by 67
Metadata
- Authors
- Laish, I., Braun, M., Mor, E., Sulkes, J., Harif, Y., & Ari, Z. B.
- Venue
- Liver Transplantation
- Published
- 2011-01
- Volume
- 17
- Issue
- 1
- Pages
- 15-22
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W2132071692
- Cited by
- 256
- References
- 34
- FWCI
- 17.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.